Mouth Neoplasms
21
4
4
10
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
19.0%
4 terminated out of 21 trials
71.4%
-15.1% vs benchmark
5%
1 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (21)
Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals
Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.
Biomarkers for Oral Cancer
Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer
A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients
Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage
Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)
GDF15 Based TPF Induction Chemotherapy for OSCC Patients
A New Membrane Obturator Prothesis Concept for Soft Palate Defects
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity
Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity
GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers
The Feasibility Study of Dual-Section Nasogastric Tube